Imatinib-induced cytogenetic remission in chronic eosinophilic leukaemia.
Willson
A
A
Cannell
P
P
Joske
D
D
Augustson
B
B
D001549:Benzamides; D002908:Chronic Disease; D020732:Cytogenetic Analysis; D004802:Eosinophilia / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction
D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate